Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenic protein therapy.

Marc Ruel1, Frank W Sellke

  • 1Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Canada.

Seminars in Thoracic and Cardiovascular Surgery
|September 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incretin-based therapies and altered myocardial metabolism in a swine model of ischemic heart disease in the setting of metabolic syndrome.

Surgery·2026
Same author

Microcirculation dysfunction and cardioprotection in cardiac surgery with cardiopulmonary bypass: mechanisms, monitoring, and therapeutic strategies.

Frontiers in cardiovascular medicine·2026
Same author

Prediction of Cyanotic Congenital Heart Disease Risk in U.S. Births.

Journal of cardiovascular development and disease·2026
Same author

Gender disparities in Medicare billings among cardiothoracic surgeons.

JTCVS open·2026
Same author

Cardiopulmonary bypass time, intraoperative hematocrit and transfusion predict neurocognitive decline in patients undergoing cardiac surgery.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

Linagliptin enhances coronary microvascular function and collateralization in a large animal model of cardiometabolic syndrome.

Microvascular research·2026
Same journal

A Systematic Review on the Impact of Postoperative Rehabilitation Programs in Thoracic Surgery Patients.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Endoscopic vs. Operative Management of Acute Esophageal Perforation: A 21-Year Experience at a High-Volume Referral Center.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Valved Sano Conduit During the Norwood Procedure: A Contemporary Review of Early Outcomes, Reintervention Burden, and Pulmonary Artery Growth.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Propensity Score-Matched Analysis Comparing Modified Konno Procedure and Transaortic Septal Myectomy in Children With Left Ventricular Outflow Tract Obstruction.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Post-Operative Hemothorax: Uniportal Video-Assisted Thoracic Surgery vs Thoracotomy-Analysis of Outcomes and Costs.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Palliative Care Throughout the Entire Perioperative Pathway in Cardiovascular Surgery.

Seminars in thoracic and cardiovascular surgery·2026
See all related articles

Therapeutic angiogenesis shows promise for treating severe coronary artery disease by improving blood flow. Further research is needed to confirm its role in standard treatment for ischemic heart disease.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Molecular Biology

Background:

  • Therapeutic angiogenesis is a novel treatment strategy for inoperable coronary artery disease.
  • Growth factor administration or gene therapy aims to stimulate new blood vessel formation.
  • Animal models show improved myocardial perfusion and function with angiogenic factors.

Purpose of the Study:

  • To evaluate the potential of therapeutic angiogenesis as a treatment for severe, inoperable coronary artery disease.
  • To assess the long-term effects of angiogenic therapy on angina and myocardial perfusion.
  • To identify limitations and future research directions for angiogenesis in ischemic heart disease.

Main Methods:

  • Review of animal models demonstrating the efficacy of angiogenic growth factors.

Related Experiment Videos

  • Analysis of a clinical study on FGF-2 protein therapy for coronary artery disease.
  • Emphasis on the need for randomized, double-blind, placebo-controlled trials.

    • Main Results:

    • Beneficial long-term effects reported in a clinical study using FGF-2 protein therapy.
    • Improvements observed in freedom from angina and myocardial perfusion on nuclear imaging.
    • Potential to expand treatment options for patients unsuitable for conventional revascularization.

    Conclusions:

    • Therapeutic angiogenesis, particularly protein therapy, shows potential for treating coronary artery disease.
    • Further rigorous clinical trials are essential to establish its role in standard care.
    • Overcoming limitations like antiangiogenic factors and patient response is crucial for widespread adoption.